Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Padcev
Pharma
Keytruda, Padcev cut risk of death by 50% in MIBC patient subset
The perioperative PD-1/ADC combo also significantly improved event-free survival by 60% versus surgery alone.
Angus Liuu
Oct 18, 2025 10:30am
Roche touts Tecentriq biomarker win in bladder cancer
Aug 18, 2025 4:17pm
Padcev-Keytruda result, Alzheimer's med, Fosun—Fierce Pharma Asia
Aug 15, 2025 8:31am
Padcev-Keytruda combo delivers bladder cancer 'breakthrough'
Aug 12, 2025 11:16am
Astellas shifts investment focus to later-stage programs: exec
Feb 12, 2025 1:30pm
Pfizer cranks up revenue outlook amid Paxlovid sales bump
Oct 29, 2024 10:40am
